MFS
ALXN

MSI Financial Services’s Alexion Pharmaceuticals ALXN Stock Holding History

MSI Financial Services’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$392K Sell
3,203
-1,087
-25% -$133K 0.01% 801
2016
Q3 		$526K Buy
4,290
+44
+1% +$5.66K 0.02% 655
2016
Q2 		$496K Sell
4,246
-709
-14% -$101K 0.02% 638
2016
Q1 		$690K Buy
4,955
+929
+23% +$136K 0.03% 487
2015
Q4 		$768K Buy
4,026
+2,767
+220% +$483K 0.03% 435
2015
Q3 		$197K Buy
1,259
+568
+82% +$104K 0.02% 652
2015
Q2 		$125K Sell
691
-3
-0.4% -$518 0.01% 904
2015
Q1 		$120K Buy
694
+11
+2% +$1.99K 0.01% 941
2014
Q4 		$126K Sell
683
-97
-12% -$18K 0.01% 724
2014
Q3 		$129K Buy
780
+11
+1% +$1.81K 0.02% 730
2014
Q2 		$120K Sell
769
-159
-17% -$25.1K 0.02% 742
2014
Q1 		$141K Sell
928
-757
-45% -$120K 0.02% 647
2013
Q4 		$224K Buy
1,685
+210
+14% +$25.2K 0.03% 457
2013
Q3 		$171K Sell
1,475
-333
-18% -$36.5K 0.03% 494
2013
Q2 		$167K Buy
+1,808
New +$174K 0.03% 468

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

MSI Financial Services's ALXN Position: Q4 2016 in Review

MSI Financial Services reduced its Alexion Pharmaceuticals (ALXN) stake by 25% in Q4 2016, selling an estimated $133K and leaving 3,203 shares worth $392K. The position accounts for 0.01% of the portfolio, ranked #801.

MSI Financial Services first reported a position in ALXN in Q2 2013 and has held it in 15 quarters since. The position peaked at $768K in Q4 2015. 548 funds tracked by Wall St. Rank hold ALXN as of Q4 2016.

  • MSI Financial Services held 3,203 shares of Alexion Pharmaceuticals worth $392K as of Q4 2016.
  • MSI Financial Services sold 1,087 Alexion Pharmaceuticals shares in Q4 2016, an estimated $133K.
  • Alexion Pharmaceuticals made up 0.01% of MSI Financial Services's portfolio in Q4 2016, its #801 holding.
  • MSI Financial Services first reported a position in Alexion Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • MSI Financial Services's Alexion Pharmaceuticals position peaked at $768K in Q4 2015.
  • 548 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.